Longitudinal features of stir bright signal in FSHD1

Muscle and Nerve

Volumn 49, Issue 2, 2014, Pages 257-260

  Friedman, Seth D ^a   Poliachik, Sandra L ^a   Otto, Randolph K ^a,b   Carter, Gregory T ^b   Budech, Christopher B ^a   Bird, Thomas D ^b   Miller, Daniel G ^b   Shaw, Dennis W W ^a,b  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Facioscapulohumeral muscular dystrophy; Longitudinal; Magnetic resonance; Muscle; Muscular dystrophy

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRIGHTNESS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; MIDDLE AGED; MUSCLE ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RADIOLOGIST; SHORT TAU INVERSION RECOVERY BRIGHTNESS;

ADULT; AGED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL;

EID: 84892499543     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23911     Document Type: Article

References (20)

1. de Greef JC, Wohlgemuth M, Chan OA, Hansson KB, Smeets D, Frants RR, et al. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology 2007;69:1018-1026.
2. van der Maarel SM, Tawil R, Tapscott SJ. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends Mol Med 2011;17:252-258.
3. Cabianca DS, Gabellini D. The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy. J Cell Biol 2010;191:1049-1060.
4. Wallace LM, Liu J, Domire JS, Garwick-Coppens SE, Guckes SM, Mendell JR, et al. RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy. Mol Ther 2012;20:1417-1423.
5. Friedman SD, Poliachik SL, Carter GT, Budech CB, Bird TD, Shaw DW. The magnetic resonance imaging spectrum of facioscapulohumeral muscular dystrophy. Muscle Nerve 2012;45:500-506.
6. Kan HE, Scheenen TW, Wohlgemuth M, Klomp DW, van Loosbroek-Wagenmans I, Padberg GW, et al. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2009;19:357-362.
7. Frisullo G, Frusciante R, Nociti V, Tasca G, Renna R, Iorio R, et al. CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol 2011;31:155-166.
8. Tasca G, Pescatori M, Monforte M, Mirabella M, Iannaccone E, Frusciante R, et al. Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PLoS One 2012;7:e38779.
9. Kan HE, Klomp DW, Wohlgemuth M, van Loosbroek-Wagemans I, van Engelen BG, Padberg GW, et al. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism. NMR Biomed 2010;23:563-568.
10. Stubgen JP. Facioscapulohumeral muscular dystrophy. A quantitative electromyographic study. Electromyogr Clin Neurophysiol 2007;47:175-182.
11. Mercuri E, Pichiecchio A, Counsell S, Allsop J, Cini C, Jungbluth H, et al. A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 2002;6:305-307.
12. Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011;76:346-353.
13. Carter GT, Abresch RT, Fowler WM Jr. Adaptations to exercise training and contraction-induced muscle injury in animal models of muscular dystrophy. Am J Phys Med Rehabil 2002;81(Suppl):S151-S161.
14. Carter GT, Wineinger MA, Walsh SA, Horasek SJ, Abresch RT, Fowler WM, Jr. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord 1995;5:323-332.
15. Carter GT, Abresch RT, Walsh SA, Wineinger MA. The mdx mouse diaphragm: exercise-induced injury. Muscle Nerve 1997;20:393-394.
16. Miro J, Gertz KJ, Carter GT, Jensen MP. Chronic pain in neuromuscular disease: pain site and intensity differentially impacts function. Phys Med Rehabil Clin N Am 2012;23:895-902.
17. Jensen MP, Hoffman AJ, Stoelb BL, Abresch RT, Carter GT, McDonald CM. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil 2008;89:320-328.
18. van der Kooi EL, Kalkman JS, Lindeman E, Hendriks JC, van Engelen BG, Bleijenberg G, et al. Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy. J Neurol 2007;254:931-940.
19. Hassan A, Jones LK Jr, Milone M, Kumar N. Focal and other unusual presentations of facioscapulohumeral muscular dystrophy. Muscle Nerve 2012;46:421-425.
20. Bushby KM, Pollitt C, Johnson MA, Rogers MT, Chinnery PF. Muscle pain as a prominent feature of facioscapulohumeral muscular dystrophy (FSHD): four illustrative case reports. Neuromuscul Disord 1998;8:574-579.